Kathy Gratton
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- CAR-T cell therapy research
- PARP inhibition in cancer therapy
- Peptidase Inhibition and Analysis
Papers in
- Oncology 9
- PARP inhibition in cancer therapy 4
- CAR-T cell therapy research 3
- Co-authors
- Nizar J. Bahlis (14 shared papers)Douglas A. Stewart (13 shared papers)Paola Neri (13 shared papers)Peter Duggan (11 shared papers)Adnan Mansoor (6 shared papers)Li Ren (5 shared papers)Alexander C. Klimowicz (3 shared papers)Lawrence Boise (2 shared papers)
- Journals
- Blood (14 papers)Cancer Immunology Research (1 paper)Clinical Cancer Research (1 paper)The Journal of Immunology (1 paper)The American Journal of Human Genetics (1 paper)
- Partner nations
- CanadaUnited StatesItaly
In The Last Decade
Kathy Gratton
21 papers receiving 429 citations
Peers
Comparison fields: 5 of 51
- Hematology 172
- Oncology 172
- Molecular Biology 276
- Genetics 83
- Immunology 54
Countries citing papers authored by Kathy Gratton
This map shows the geographic impact of Kathy Gratton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Gratton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Gratton more than expected).
Fields of papers citing papers by Kathy Gratton
This network shows the impact of papers produced by Kathy Gratton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Gratton. The network helps show where Kathy Gratton may publish in the future.
Co-authors
The 25 scholars most cited alongside Kathy Gratton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 134 | |
| 2 | 2011 | 126 | |
| 3 | 2018 | 48 | |
| 4 | 2016 | 33 | |
| 5 | 1998 | 31 | |
| 6 | 2019 | 21 | |
| 7 | 2012 | 10 | |
| 8 | 2009 | 7 | |
| 9 | 2013 | 5 | |
| 10 | 2012 | 4 | |
| 11 | 2011 | 4 | |
| 12 | 2011 | 4 | |
| 13 | 2016 | 2 | |
| 14 | 2013 | 2 | |
| 15 | 2015 | 2 | |
| 16 | 2005 | 1 | |
| 17 | Development of a YAC contig covering the minimal region of a CSNB1 locus in Xp11 | 1994 | 1 |
| 18 | 2010 | 1 | |
| 19 | 2012 | 1 | |
| 20 | 2009 | 1 |
About Kathy Gratton
Kathy Gratton is a scholar working on Molecular Biology, Oncology, Hematology, Genetics and Cancer Research, having authored 24 papers that have together received 440 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Virus-based gene therapy research (5 papers), PARP inhibition in cancer therapy (4 papers), Cancer Research and Treatments (4 papers), CAR-T cell therapy research (3 papers), Cancer Mechanisms and Therapy (3 papers), Cell Adhesion Molecules Research (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Hematology (172 citations), Oncology (172 citations), Molecular Biology (276 citations), Genetics (83 citations) and Immunology (54 citations). Kathy Gratton has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Nizar J. Bahlis, Douglas A. Stewart, Paola Neri, Peter Duggan, Adnan Mansoor, Li Ren, Alexander C. Klimowicz, Lawrence Boise, Pierfrancesco Tassone and Ahmed Mostafa. Their work appears in journals such as Blood, Cancer Immunology Research, Clinical Cancer Research, The Journal of Immunology and The American Journal of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.